|
000
| 01506cam 2200325za 4500 |
|---|
| 001 | 9.856492 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107155537 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180511t19851986onc #ob f000 0 eng d |
|---|
| 020 | |z0-662-14499-6 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aRG48-1/8-1986E-PDF|zRG48-1/8-1986E |
|---|
| 100 | 1 |aGoyer, Robert. |
|---|
| 245 | 10|aRegulatory aspects and their influence on pharmaceutical research and on the introduction of drugs in Canada |h[electronic resource] / |cRobert Goyer. |
|---|
| 260 | |a[Ottawa?] : |b[Economic Council of Canada] : |bCommission of Inquiry on the Pharmaceutical Industry, |c1985, c1986. |
|---|
| 300 | |a170, [27] p. |
|---|
| 500 | |a"February 1985." |
|---|
| 500 | |a"Background study"--Cover. |
|---|
| 500 | |aDigitized edition from print [produced by the Publishing and Depository Services Directorate]. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The objectives of this study were to review the Current Canadian Regulations concerning Drugs, especially New Drugs, as well as the present organizational structure at HPB"--Objectives, p. 1. |
|---|
| 692 | 07|2gccst|aDrugs |
|---|
| 692 | 07|2gccst|aPharmaceutical industry |
|---|
| 692 | 07|2gccst|aRegulations |
|---|
| 710 | 1 |aCanada. |bIndustry Canada. |
|---|
| 710 | 1 |aCanada. |bCommission of Inquiry on the Pharmaceutical Industry. |
|---|
| 710 | 2 |aEconomic Council of Canada. |
|---|
| 856 | 40|qPDF|s18.63 MB|uhttps://publications.gc.ca/collections/collection_2018/ecc/RG48-1-8-1986-eng.pdf |
|---|